Treatment of Kawasaki disease with anti-TNF antibodies

Lancet. 2014 May 17;383(9930):1700-3. doi: 10.1016/S0140-6736(14)60131-8. Epub 2014 Feb 24.

Authors

Michael Levin¹, David Burgner²

Affiliations

¹ Section of Paediatrics, Faculty of Medicine, Imperial College London, London W2 1PG, UK. Electronic address: m.levin@imperial.ac.uk.
² Murdoch Childrens Research Institute, VIC, Australia; University of Melbourne, VIC, Australia; Monash Children's Hospital, VIC, Australia.

PMID: 24572998
DOI: 10.1016/S0140-6736(14)60131-8

No abstract available

Publication types

Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Female
Humans
Infliximab
Male
Mucocutaneous Lymph Node Syndrome / drug therapy*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antibodies, Monoclonal
Infliximab